Sanofi
SNY
$48.61
Share price
-1.48%
Change (1 day)
-5.30%
Change (1 year)
Categories
Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthélabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.
Revenue for Sanofi (SNY)
Revenue in 2025 (TTM): $47.39 Billion USD
According to Sanofi's latest financial reports the company's current revenue (TTM 
) is $47.39 Billion USD. In 2024 the company made a revenue of $46.42 Billion USD a decrease over the revenue in the year 2023 that were of $50.39 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sanofi from 2003 to 2025
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2025 (TTM) | $47.39 B | 2.11% |
| 2024 | $46.42 B | -7.88% |
| 2023 | $50.39 B | 6.02% |
| 2022 | $47.52 B | 4.52% |
| 2021 | $45.47 B | |
| 2019 | $42.01 B | 0.26% |
| 2018 | $41.90 B | 0.95% |
| 2017 | $41.51 B | 8.34% |
| 2016 | $38.31 B | 3.94% |
| 2015 | $36.86 B | -17.01% |
| 2014 | $44.42 B | 0.3% |
| 2013 | $44.29 B | -5.28% |
| 2012 | $46.75 B | -3.29% |
| 2011 | $48.35 B | 13.91% |
| 2010 | $42.44 B | -1.85% |
| 2009 | $43.24 B | 0.9% |
| 2008 | $42.86 B | 4.27% |
| 2007 | $41.10 B | 10.33% |
| 2006 | $37.25 B | 8.15% |
| 2005 | $34.44 B | 76.96% |
| 2004 | $19.46 B | 107.64% |
| 2003 | $9.37 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Merck MRK | $63.92 B | 34.86% | 🇺🇸 USA |
 Pfizer PFE | $62.46 B | 31.78% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $47.63 B | 0.50% | 🇺🇸 USA |
 Novartis NVS | $53.22 B | 12.29% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | $40.58 B | -14.37% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $16.61 B | -64.95% | 🇮🇱 Israel |
 Johnson & Johnson JNJ | $89.33 B | 88.47% | 🇺🇸 USA |
 Eli Lilly LLY | $49.00 B | 3.39% | 🇺🇸 USA |
 Novo Nordisk NVO | $43.73 B | -7.74% | 🇩🇰 Denmark |
 Abbott Laboratories ABT | $42.34 B | -10.66% | 🇺🇸 USA |